bio in Medical Technology
Navigation Links
bio in Medical Technology
CAMBRIDGE, Mass., June 17 /PRNewswire/ -- Peptimmune, Inc. a privately
held biotechnology company, announced that physicians have treated the
first participant in a clinical trial to evaluate the safety, tolerability,
pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with
Secondary...
ATLANTA, Jan. 17 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing HIV-1/AIDS vaccines, announced it has been named a "2008 Deal of the Year" award winner by Georgia Bio. Georgia Bio recognized GeoVax for receiving a $15 m...
...t also intends to enter into one to two new collaborations with corporate partners in 2009. Our next formal company presentation will be at the bio CEO Conference February 9 and 10, 2009, in New York, NY. About BiTE Antibodies BiTE(R) antibodies are designed to direct the body's cyt...
..., Belgium, where the majority of GlaxoSmithKline's activities in the field of vaccine research, development and production are conducted. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries. Of these doses, seventy-five percent of these went to the developing world. Appr...
...he total amount raised since the company's inception to $106.5 million. All existing institutional investors participated in the financing, led by MPM bio IV NVS Strategic Fund and including MPM Capital, The Wellcome Trust, HealthCare Ventures, Oxford Bioscience Partners, BB Biotech Ventures, and Scottis...
...ib therapy for the patients with non-squamous NSCLC. The DMC will review updated data after three months. Amgen, in collaboration with Takeda bio Development Center, is implementing both of the DMC's recommendations and notifying worldwide regulatory agencies, including the U.S. Food and Drug Ad...
...array of changes that occur with aging. While future research could take several directions, including studies of risk factors like cholesterol or the bio availability of estrogen, Silverman explains that the area of gene expression offers promise at this time. While an extra copy of Chromosome 21 in a p...
...bed clinical research facility for Phase I trials, and hiring 38 full- and part-time employees over the next three years. National programs At the bio International Convention in San Diego, the KBA also kicked off its new Collaborative Cancer Research Initiative, which launches with $2.5 million in f...
... FDA Feedback Supports Innovative Co-development Model SAN DIEGO, June 17 /PRNewswire/ -- bio International Convention 2008 ( http://www.bio2008.org ) -- HUYA Bioscience International ( http://www.huyabio.com ), the leader in U.S./China pharmac...
... ASPIRE IRB Is Exhibiting at bio International Convention in San Diego June 17-20 Currently, over 54,255 Trials with Locations in 154 Countries Are T...
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...ts to prevent infections that cause serious medical problems worldwide. GSK bio is also developing innovative immunotherapy compounds to treat cancer patie...
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
... field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
...PR-B agonist being developed for the treatment of heart failure. The results of this study will be included in the Company's presentation today at the bio Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on blood pre...
...PR-B agonist being developed for the treatment of heart failure. The results of this study will be included in the Company's presentation today at the bio Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on blood pre...
...ersllc.com david.schull@russopartnersllc.com Editors Note: Alacrity Biosciences will present at 12:30 p.m. PDT on Thursday, Oct. 11, 2007, at the bio InvestorForum in San Francisco. ...
...e field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...ts to prevent infections that cause serious medical problems worldwide. GSK bio is also developing innovative immunotherapy compounds to treat cancer patie...
Nventa to Present at Bio 2008 International Convention
SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today that the Company's vice president of corporate development, Richard Lai Fatt, Ph.D., is scheduled to present a Company overview at the Business Forum during the Biotechnology Industry ...Genetic Immunity to Present at 2008 BIO International Convention
MCLEAN, Va. and BUDAPEST, Hungary, June 12 /PRNewswire/ -- Genetic Immunity, a US/Hungarian clinical-stage Company focused on the development of its patented nanomedicines for targeted immune amplification, announced today that the Company will be presenting at the 2008 Bio International Conve...OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody
AMSTERDAM, April 15 /PRNewswire/ -- SynCo Bio Partners B.V., a leading GMP biopharmaceutical manufacturer, has signed a Master Services Agreement with OncoMed Pharmaceuticals, a company developing novel therapeutics that target cancer stem cells. Under the agreement, SynCo will fill and finish...Pharmacopeia to Present at BIO CEO & Investor Conference 2008
PRINCETON, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, today announced that Dr. Leslie J. Browne, President and Chief Executive Officer, will deliver a corporate presentation at the BIO ...ATLANTA, Jan. 17 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company developing HIV-1/AIDS vaccines, announced it has been named a "2008 Deal of the Year" award winner by Georgia Bio. Georgia Bio recognized GeoVax for receiving a $15 m...
Oculus Innovative Sciences to Present at 4th Annual BIO InvestorForum Conference
PETALUMA, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Oculus Innovative Sciences, Inc. (Nasdaq: OCLS ) announced today that the company will be presenting at the 4th Annual BIO InvestorForum Conference to be held October 9-11, 2007 at the Palace Hotel of San Francisco. The company's president an...Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
BOTHELL, Wash., April 18, 2007 /PRNewswire-FirstCall/ -- Helix BioMedix, Inc. today announced that Timothy Falla, Ph.D, Chief Scientific Officer, will present an update on the company's new generation of small molecule peptide (lipohexapeptide) technology at the BIO International Convention. The c...Karo Bio Announces Sucessfule Phase II Results of KB2115
HUDDINGE, Sweden,11-Jun-2007 / Karo Bio (STO:KARO) successful KB2115 Phase II study meets primary objectives. The 12 week proof of concept phase II study with KB2115 in patients with dyslipidemia has been successfully completed. KB2115 is efficacious in LDL lowering and safe with respect to a broad...GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
...ising recent stock price, substantial increase in the number of new investors in GeoVax, substantial press coverage and investor interest at the World bio Conference in Atlanta, invitations to present GeoVax at various investor conferences and several scientific presentations and publications by Dr. Robi...Type 2 Diabetes: An Epidemic Among America's Youth
...ediabetes, type 1 and type 2 diabetes, diabetes complications, and tips on how diabetes patients can best prepare for disaster. A short, one page bio and high resolution photo of Francine R. Kaufman, MD, is available by clicking here . About AACE AACE is a professional medical orga...Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient
...em at risk for developing type 2 diabetes and cardiovascular complications. To download these recommendations click here . A short, one-page bio and high resolution photo of Howard S. Weintraub, MD, is available here . About AACE AACE is a professional medical organization with...Spherix Reports First Quarter 2009 Earnings
... Trade shows/investor conferences: Ohio Valley Affiliates for Life Science, Dayton, OH, April 2-3 bio International Convention, Atlanta, GA, May 18-21 Rodman & Renshaw 11th Annual Health Conference, New York, NY, Sept. 9-11 ...BARC Central Laboratory Joins Alzheimer's Association Research Roundtable
...lzheimer's disease by collectively addressing obstacles to research and development, clinical care, and public health education. About BARC bio Analytical Research Corporation (BARC) is a leading global central laboratory and is currently running 400 different protocols involving more than 8,0...Drug Development Program Started Based on CAP(R) Human Cell Line
...cht, The Netherlands) announce the start of Theraptech, a 2.4 million Euro therapeutic protein development program subsidized under the European Trans bio Program. The major objective of the Theraptech project is to develop a recombinant human alkaline phosphatase (rhuAP) using the novel versatile human ...Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
..., President and CEO of Genaera, presented data from the first of three cohorts in an ascending multiple dose study of MSI-1436 (Study 102), during the bio CEO & Investor Conference in New York. Data from cohort 1, in which eight doses of 3 mg/m2 of MSI-1436 were administered over 21 days to ove......t also intends to enter into one to two new collaborations with corporate partners in 2009. Our next formal company presentation will be at the bio CEO Conference February 9 and 10, 2009, in New York, NY. About BiTE Antibodies BiTE(R) antibodies are designed to direct the body's cyt...
..., Belgium, where the majority of GlaxoSmithKline's activities in the field of vaccine research, development and production are conducted. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries. Of these doses, seventy-five percent of these went to the developing world. Appr...
...he total amount raised since the company's inception to $106.5 million. All existing institutional investors participated in the financing, led by MPM bio IV NVS Strategic Fund and including MPM Capital, The Wellcome Trust, HealthCare Ventures, Oxford Bioscience Partners, BB Biotech Ventures, and Scottis...
...ib therapy for the patients with non-squamous NSCLC. The DMC will review updated data after three months. Amgen, in collaboration with Takeda bio Development Center, is implementing both of the DMC's recommendations and notifying worldwide regulatory agencies, including the U.S. Food and Drug Ad...
...array of changes that occur with aging. While future research could take several directions, including studies of risk factors like cholesterol or the bio availability of estrogen, Silverman explains that the area of gene expression offers promise at this time. While an extra copy of Chromosome 21 in a p...
NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
...ting: Kurt Praschak / Success Communications Group 973.992-7800, x.289 / kpraschak@successcomgroup.com -- Background Information A bio of Dr. Carl Giordano, along with a one-page fact sheet on Total Disc Replacement, is available at the following links: http://tinyurl.com/CarlGiordan...New Australian Technology: Detecting Breast Cancer With Hair
...cessary invasive procedures such as biopsies. The NSW Minister for Science and Medical Research, the Hon. Verity Firth highlighted the comparison at bio 2008, the world's largest biotech convention held in San Diego [June 17-20] this week. The Minister noted that the Sydney company, recently named th......bed clinical research facility for Phase I trials, and hiring 38 full- and part-time employees over the next three years. National programs At the bio International Convention in San Diego, the KBA also kicked off its new Collaborative Cancer Research Initiative, which launches with $2.5 million in f...
... FDA Feedback Supports Innovative Co-development Model SAN DIEGO, June 17 /PRNewswire/ -- bio International Convention 2008 ( http://www.bio2008.org ) -- HUYA Bioscience International ( http://www.huyabio.com ), the leader in U.S./China pharmac...
... ASPIRE IRB Is Exhibiting at bio International Convention in San Diego June 17-20 Currently, over 54,255 Trials with Locations in 154 Countries Are T...
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...ts to prevent infections that cause serious medical problems worldwide. GSK bio is also developing innovative immunotherapy compounds to treat cancer patie...
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot......he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
... field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
...PR-B agonist being developed for the treatment of heart failure. The results of this study will be included in the Company's presentation today at the bio Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on blood pre...
...PR-B agonist being developed for the treatment of heart failure. The results of this study will be included in the Company's presentation today at the bio Investor Forum in San Francisco, CA. "The development of a peptide that has natriuretic and renal effects, with relatively little effect on blood pre...
...ersllc.com david.schull@russopartnersllc.com Editors Note: Alacrity Biosciences will present at 12:30 p.m. PDT on Thursday, Oct. 11, 2007, at the bio InvestorForum in San Francisco. ...
...e field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
...ficance of this data lies in the fact that CEL-1000 appears to be able to mount a faster immune response, something that is absolutely necessary for a bio defense or a pandemic flu setting, as well as the potential ability to create more effective immune responses through the use of CEL-1000 as an adjuva...K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
...f the primary reasons that the federal government should build the National bio and Agro-Defense Facility in Manhattan." Richt, will kick off the symposiu...souri has already endorsed Manhattan as the preferred home for the National bio and Agro-Defense Facility and, along with the unparalleled concentration of......he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
Pluristem to Present Two Scientific Posters at the International Society for Cellular Therapy
...taining high-density 3-D culture." Pluristem will also attend the 2007 bio International Convention being held at the Boston Convention & Exhibition Center from May 6-9, 2007. bio represents more than 1,100 biotechnology companies, academic institutions, ......he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...vent infections that cause serious medical problems worldwide. In 2006, GSK bio distributed more than 1.1 billion doses of vaccines to 169 countries in bot...
...he field of vaccine research, development and production are conducted. GSK bio employs more than 1,500 scientists, who are devoted to discovering new vacc...ts to prevent infections that cause serious medical problems worldwide. GSK bio is also developing innovative immunotherapy compounds to treat cancer patie...
Other TagsEliminatePrescriptionSugarSugarSugarFutureFutureFutureRadioRadioRadioMotherMotherMotherMotherMotherMakingMakingMakingStructureStructureStructureHydrogenHydrogenHydrogenHydrogenNatureNatureNatureImportantImportantImportantOther Contentsjointjointjointjointjointjointjointjointkaryotypekeratinkeratinkeratinkidneykidneykidneykidneykidneykidneykidneykidneykidneykinesiologykinetickinetickinetickinetickinetic
EliminatePrescriptionSugarCharacterizingPHACCSFutureCousinRadioMotherMakingStructureHydrogenNatureImportant
(Date:11/30/2009)... Neurotechnology ( http://www.neuro...metric identification technologies, has released t...: VeriLook 4.0 Software Development Kit (SDK) fo... large-scale multi-biometric and automated fingerp...ilities in VeriLook 4.0 provide enhanced facial re...
(Date:11/26/2009)...sing recordings of birdsong to accurately measure ...me sound recordings from a microphone array have b...cies, populations. Because the new technique, repo...of Applied Ecology , will also work with whale son... to monitor whale and dolphin numbers. , Develop...
(Date:11/26/2009)...ureus ) and other drug-resistant bacteria could fa...e devices have been developed to offer safe, quick...wo prototype devices have been developed: one for ... and feet) in hospitals and public spaces where ba...oot bacteria-killing agents into infested chronic ...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Ecologists sound out new solution for monitoring cryptic species 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 1Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 2Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 3Dynatronics to Release Fourth Quarter and Year end Results Friday September 25 2009 3B Conference Call Set for 12 3A30 p m ET 58182 1Aviva Family and Childrens Services Hosts Rededication Ceremony of the Newly Renovated Wallis Annenberg Center 58180 1Aviva Family and Childrens Services Hosts Rededication Ceremony of the Newly Renovated Wallis Annenberg Center 58180 2(Date:12/1/2009)... , , NEWPORT BEACH, Calif., Dec. 1 /PRN...lling code that insurers will reimburse them for t...n monitor for ,going under, for surgery. ,, Ane...nt brain monitoring is to avoid postop dementia fr...hesiologists have not heard the ,avoid over-medica...
(Date:12/1/2009)... , , SEATTLE, Dec. 1 /PRNewswire-F... and MTA: CTIC) management,s presentation at the 2... Tuesday, December 1 at 11:00 a.m. Eastern Time wi... ,, The presentation will take place in Holmes...available for replay after the presentation. , ,...
(Date:12/1/2009)... , CHICAGO A study presented today at the annual...ica (RSNA) revealed that MRI is a highly accurate ...ly life-threatening and increasingly common condit...ust before and after giving birth. , "Due to th...s that leave scarring on the uterine wall, coupled...
(Date:12/1/2009)... , CHICAGO Results of a randomized, controlled c...g of the Radiological Society of North America (RS...g or blockage in arteries that supply blood to the...icant but silent coronary artery disease. , Per... a combination of fat, cholesterol and other subst...
(Date:12/1/2009)... , The first ever published study of aviation-rel...re than 1,013 patients are admitted to U.S. hospit...hat 753 aviation-deaths occur each year. The study...Bloomberg School of Public Health,s Center for Inj...lso reports that the largest categories of patient...
Breaking Medicine News(10 mins):Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2[0] 5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed[0] Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast[0] MRI helps detect life-threatening pregnancy complication[0] Severe asymptomatic heart disease may accompany narrowing in leg arteries[0] More than 1,000 patients in US admitted annually for aviation-related injuries
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |